Bradley Pharmaceuticals
Company type | Merged |
---|---|
Industry | Pharmaceuticals |
Founded | 1985; 39 years ago (1985) |
Fate | closed February 21, 2008 |
Successor | Nycomed |
Headquarters | Fairfield Township, Essex County, New Jersey |
Key people | Daniel Glassman (CEO) |
Products | Adoxa, Zoderm, Pamine Forte, Kerol |
Revenue | US$145 million (2006) |
Number of employees | 300 (as of December 31, 2006) |
Bradley Pharmaceuticals was a pharmaceutical company headquartered in Fairfield Township, Essex County, New Jersey.[1] The company was founded in 1985 by Daniel Glassman who was also its CEO.
The company marketed to niche physician specialties in the U.S. and 38 international markets. Bradley Pharmaceuticals comprised Doak Dermatologics, specialized in therapies for dermatology and podiatry; Kenwood Therapeutics, providing gastroenterology, OB/GYN and other internal medicine brands; and A. Aarons, which markets authorized generic versions of Doak and Kenwood therapies.
Doak Dermatologics
Doak Dermatologics was the division of Bradley Pharmaceuticals, that marketed products to dermatologists. Its flag products were Zoderm which is a topical anti-acne product. Adoxa (doxycycline) was an antibiotic intended to treat mild to severe acne.
Kenwood Therapeutics
Kenwood was the affiliate brand that worked with therapeutic products. Among the most prescribed ones were Entsol which is a respiratory therapeutic product and Pamine which is intended to treat digestive problems.
Public trading
The company was publicly traded at the NYSE by its code BDY, since May 2003.
Nycomed Merger
Bradley Pharmaceuticals merged with Nycomed, a European company. The merger was completed on February 21, 2008, and Bradley became an integral part of Nycomed.[2]
References
- v
- t
- e
- Abbott Laboratories
- AbbVie Inc.
- Acorda Therapeutics
- Advaxis
- Alcon
- Alexion
- Alnylam
- Amgen
- Amneal Pharmaceuticals
- Avax Technologies
- Baxter
- BioCryst
- Biogen
- Bioverativ
- Biovest
- Biovista
- Bristol Myers Squibb
- Century
- Ceragenix
- Combe
- CytoSport
- CytRx
- Danco Laboratories
- Eli Lilly
- Galena Biopharma
- Genentech
- Gilead Sciences
- Ionis
- Institute for OneWorld Health
- Intercept
- Johnson & Johnson
- Kinetic Concepts
- McKesson
- Melinta Therapeutics
- Melior Discovery
- Mentholatum
- Merck & Co.
- Merrimack Pharmaceuticals
- Myriad Genetics
- Moderna
- Northwest Biotherapeutics
- Norwich Pharma
- NovaBay
- Organon
- Ovation
- Pfizer
- Pharmaceutical Product Development
- Prasco Laboratories
- Procter & Gamble
- Proteon Therapeutics
- Purdue Pharma
- Quark
- Regeneron
- RespireRx
- Sarepta Therapeutics
- Sheffield
- Spectrum
- Tec Laboratories
- Titan
- Trevena Inc
- Ultragenyx
- Upsher-Smith
- Ventria Bioscience
- Vertex
- Viatris
- West Pharmaceutical Services
Tax inversion |
|
---|---|
Other |
|